INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
05/19/2026
Back to search
Official data from USPTO
REXULTI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
05/20/2026
Classification
Registered
Trademark type
Word
Nice classes
10
Filing date
12/14/2017
Registration date
03/05/2019
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/19/2025
Last transaction
05/20/2026
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Tokyo, JP
Examiner
PARK, JENNY K
Law office
L40
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Otsuka Pharmaceutical Co., Ltd.
Representatives
Kazuyo Morita Holland & Hart LLP
Technical classification
Nice Classes
Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical apparatus and instruments for use in diagnosing and monitoring vital signs of patients with psychiatric and neurological disorders and diseasesdementiaAlzheimer's disorder and diseasedizzinessseizuresstrokedepressioncognitive impairmentcognitive disorders and diseasesmood disorderspsychosisanxietyapathyepilepsyLennox-Gastaut syndrome (LGS)sclerosisporphyriaHuntington's disorder and diseaseinsomniaParkinson's disorder and diseasefallsmovement disorders and diseasestremorschizophreniabipolar disorder and diseasemaniaADHDPTSDagitationaggressionautismmelancholyOCDTourette's syndromeprogressive supranuclear palsy (PSP)restlessnessakathisiafatiguesomnolencenauseacancermigrainepainalcoholism and dependency; Injection devices for medical purposes; syringes and needles for injections and medical purposes; Apparatus and instruments for diagnostic purposesintegrated medical systems comprising medical diagnostic imaging apparatus and software sold as a unit therewith for managingmeasuringmonitoringassessingcontrollingcollectingstoringexamining patient and client data and information captured by the medical system in web-based physicalpsychological and neurological examinations conducted at a distance and at a clinic; Medical apparatus and units for dosagemeasuring and monitoringdrug delivery devices and systems
Publications
History of USPTO decisions and trademark events.
30 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/19/2026
C71T
CANCELLED SECTION 71
09/19/2025
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/05/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/12/2019
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/26/2019
FIMP
FINAL DISPOSITION PROCESSED
06/26/2019
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/05/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
03/05/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/18/2018
PUBO
PUBLISHED FOR OPPOSITION
12/18/2018
GPNX
NOTIFICATION PROCESSED BY IB
12/15/2018
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/28/2018
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/28/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/28/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/08/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/23/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/23/2018
ALIE
ASSIGNED TO LIE
10/17/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/08/2018
RFNT
REFUSAL PROCESSED BY IB
05/12/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/23/2018
RFRR
REFUSAL PROCESSED BY MPU
04/23/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/18/2018
CNRT
NON-FINAL ACTION WRITTEN
04/17/2018
MAFR
APPLICATION FILING RECEIPT MAILED
04/14/2018
DOCK
ASSIGNED TO EXAMINER
04/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/10/2018
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
04/09/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/05/2018
Continuous trademark protection
Get notified about every new filing that threatens REXULTI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.